| Financial Year |
March 31 2023 |
| Monetary Funds |
90,463,568.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
132,253,327.53 |
| Advances to Suppliers |
37,811,865.10 |
| Other Receivables |
2,309,614,117.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,992,515,206.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,324,967.06 |
| Total Current Assets |
9,602,983,052.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
245,170,495.94 |
| Investment Properties |
571,243,035.58 |
| Fixed Assetes |
47,040,572.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,755.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,786,608.68 |
| Deferred Income Tax Assets |
179,263,303.51 |
| Other Non-Current Assets |
19,985,999.96 |
| Sub-Total of Non-Current Assets |
1,102,549,863.07 |
| Total Assets |
10,705,532,915.14 |
| Short-Term Loans |
585,623,416.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
885,533,892.00 |
| Accounts Received In Advance |
22,317,057.16 |
| Employee Compensation Payable |
18,118,565.52 |
| Taxes Payable |
847,590,803.00 |
| Interest Payable |
310,301,432.67 |
| Dividend Payable |
958,419.70 |
| Other payables |
1,563,597,327.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,428,800.00 |
| Other Current Liabilities |
77,153,129.24 |
| Sub-Total of Current Liabilities |
5,008,666,829.68 |
| Long-term Loans |
2,965,986,959.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
50,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,015,986,959.94 |
| Total Liabilities |
8,024,653,789.62 |
| Paid-In Capital(Or Share Stock) |
2,536,247,870.00 |
| Capital Surplus |
1,902,531,208.79 |
| Surplus Reserve |
268,501,603.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,916,583,898.07 |
| Minority Stockholder's Interest |
-121,536,046.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,802,415,171.91 |
| Owner's Equity（Stockholder's Equity） |
2,680,879,125.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,705,532,915.14 |
